Sputnik Light

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Sputnik Light
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Routes of
administration
Intramuscular
Legal status
Legal status
  • Registered in Russia on 6 May 2021

Sputnik Light (Russian: Спутник Лайт[1]) is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.[2][3][4] It actually consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector,[5] and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F). The institute says this version, with an effectiveness of 79.4%, would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly.[6]

Authorizations[edit]

  Full authorization
  Emergency authorization

References[edit]

  1. ^ "В России зарегистрировали вакцину «Спутник Лайт»". РБК (in Russian). Retrieved 7 May 2021.
  2. ^ "Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use". NDTV Coronavirus. 6 May 2021.
  3. ^ "An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine". clinicaltrials.gov.
  4. ^ "Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (SPUTNIK-LIGHT)". clinicaltrials.gov.
  5. ^ "Single dose vaccine, Sputnik Light, authorized for use in Russia" (Press release). Russian Direct Investment Fund. 6 May 2021. Retrieved 7 May 2021.
  6. ^ "Russia authorizes use of 'Sputnik Light,' a one-shot Covid vaccine it says is 79% effective". CNBC. 6 May 2021.